{"id":"fix","safety":{"commonSideEffects":[{"rate":null,"effect":"Inhibitor development (anti-Factor IX antibodies)"},{"rate":null,"effect":"Thrombotic events"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Hypersensitivity reactions"}]},"_chembl":null,"_dailymed":{"setId":"7900b6f2-a563-831c-e053-2a91aa0a558d","title":"FLU FIX (ACONITUM NAPELLUS, ALLIUM CEPA, ANIS BARBARIAE, BRYONIA ALBA, ECHINACEA ANGUSTIFOLIA, EUPATORIUM PERFOLLATUM, GELSEMIUM SEMPERVIRENS, IPECACAUANHA, NUX VOMICA, PULSATILLA, RHUS TOXICODENDRON) TABLET, CHEWABLE [GENEXA INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Hemophilia B is caused by deficiency or dysfunction of Factor IX, a critical serine protease in the intrinsic coagulation cascade. FIX (recombinant Factor IX) directly replaces this missing clotting factor, enabling the formation of the tenase complex and restoration of thrombin generation. This allows patients to achieve hemostasis and prevent or treat bleeding episodes.","oneSentence":"FIX is a recombinant coagulation Factor IX that replaces deficient or dysfunctional Factor IX to restore the intrinsic coagulation pathway in patients with hemophilia B.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:46:41.471Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hemophilia B (Factor IX deficiency) — prevention and treatment of bleeding episodes"},{"name":"Hemophilia B — perioperative management"}]},"trialDetails":[{"nctId":"NCT04275999","phase":"PHASE2","title":"Rosacea and Ivermectin","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2021-04-16","conditions":"Rosacea","enrollment":30},{"nctId":"NCT06857929","phase":"NA","title":"\"Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition\"","status":"RECRUITING","sponsor":"IMDEA Food","startDate":"2026-03-01","conditions":"Metabolic Syndrome, Obesity Prevention, Obesity and Overweight","enrollment":106},{"nctId":"NCT07223671","phase":"PHASE1","title":"Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2025-12-31","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT07498556","phase":"NA","title":"Immediate Restoration of a New Implant With High Primary Stability","status":"NOT_YET_RECRUITING","sponsor":"Universidade do Porto","startDate":"2026-03-01","conditions":"Dental Implants, Immediate Dental Implant Loading","enrollment":50},{"nctId":"NCT07494305","phase":"PHASE2","title":"Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.","status":"RECRUITING","sponsor":"LB Pharmaceuticals Inc.","startDate":"2026-01-23","conditions":"Bipolar I Disorder","enrollment":320},{"nctId":"NCT07408375","phase":"NA","title":"Effect of a Driving Pressure Adjustment Procedure for High-Frequency Jet Ventilation in Patients Undergoing Tumor Thermal Ablation in Interventional Radiology","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2026-03-13","conditions":"Solid Tumor (Excluding CNS)","enrollment":560},{"nctId":"NCT04040634","phase":"NA","title":"Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Israelita Albert Einstein","startDate":"2019-08-08","conditions":"Diabetes Mellitus, High Blood Pressure, Cardiovascular Diseases","enrollment":9476},{"nctId":"NCT06182774","phase":"PHASE3","title":"Fixed Duration vs Continuous Daratumumab in Transplant Ineligible Older Adults With Newly Diagnosed Multiple Myeloma","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2024-04-10","conditions":"Multiple Myeloma","enrollment":570},{"nctId":"NCT07494240","phase":"NA","title":"Effects of Changes in Driving Pressure on Intraoperative Pulmonary Dynamic Compliance and PaO₂/FiO₂ Ratio in Laparoscopic Sleeve Gastrectomy","status":"NOT_YET_RECRUITING","sponsor":"Beni-Suef University","startDate":"2026-04-15","conditions":"Dynamic Lung Compliance","enrollment":46},{"nctId":"NCT07113691","phase":"PHASE1","title":"Iadademstat + SBRT With Atezo in ES-SCLC","status":"RECRUITING","sponsor":"Yale University","startDate":"2026-01-20","conditions":"Extensive Stage Small Cell Lung Cancer (ES-SCLC)","enrollment":15},{"nctId":"NCT06052267","phase":"PHASE3","title":"A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations","status":"RECRUITING","sponsor":"Teva Branded Pharmaceutical Products R&D LLC","startDate":"2023-08-30","conditions":"Asthma","enrollment":2700},{"nctId":"NCT06192953","phase":"NA","title":"Early Functional Proprioceptive Stimulation Post-stroke","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2024-05-06","conditions":"Stroke (CVA) or TIA","enrollment":32},{"nctId":"NCT07463807","phase":"PHASE1, PHASE2","title":"Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-06-26","conditions":"Recurrent Multiple Myeloma, Refractory Multiple Myeloma","enrollment":162},{"nctId":"NCT06782009","phase":"NA","title":"Metabolic Impact on the Mitochondria-gut Microbiota Axis of Failure to Follow Restrictive Dietary Interventions in Subjects Living With Obesity","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2023-04-08","conditions":"Obesity","enrollment":84},{"nctId":"NCT07266831","phase":"PHASE2, PHASE3","title":"A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-12-18","conditions":"Human Immunodeficiency Virus Type 1 (HIV-1) Infection","enrollment":570},{"nctId":"NCT03824483","phase":"PHASE2","title":"Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2019-02-22","conditions":"Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Leukemia (SLL)","enrollment":230},{"nctId":"NCT06702215","phase":"NA","title":"Cortical Plasticity of the Tactile Mirror System in Borderline Personality Disorder","status":"COMPLETED","sponsor":"IRCCS Centro San Giovanni di Dio Fatebenefratelli","startDate":"2023-09-04","conditions":"Borderline Personality Disorder (BPD)","enrollment":71},{"nctId":"NCT04351256","phase":"PHASE2","title":"Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy","status":"COMPLETED","sponsor":"Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest","startDate":"2020-05-20","conditions":"NSCLC, Stage III","enrollment":51},{"nctId":"NCT04223791","phase":"PHASE3","title":"Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-18","conditions":"HIV Infection","enrollment":643},{"nctId":"NCT05880095","phase":"NA","title":"Healthy Aging Through Time- Restricted Eating in Adults With Overweight/Obesity and Incipient Liver Disease: ENSATI","status":"COMPLETED","sponsor":"IMDEA Food","startDate":"2023-07-05","conditions":"Biological Aging","enrollment":176},{"nctId":"NCT06279377","phase":"NA","title":"Examining the Effectiveness of Exercise Training After Cervical Laminoplasty Surgery","status":"COMPLETED","sponsor":"Izmir Katip Celebi University","startDate":"2023-05-05","conditions":"Cervical Spine Disease, Surgery, Rehabilitation","enrollment":32},{"nctId":"NCT05017012","phase":"PHASE1","title":"A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-09-21","conditions":"Advanced or Metastatic Solid Tumors","enrollment":72},{"nctId":"NCT07496528","phase":"NA","title":"Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection","status":"NOT_YET_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2026-04-01","conditions":"Colorectal Neoplasms, Ileus Postoperative, Postoperative Complication","enrollment":240},{"nctId":"NCT00066443","phase":"PHASE1, PHASE2","title":"Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer","status":"COMPLETED","sponsor":"NCIC Clinical Trials Group","startDate":"2003-11-03","conditions":"Breast Cancer","enrollment":93},{"nctId":"NCT07236554","phase":"NA","title":"Blood Flow Restriction Training Versus Mulligan Technique in Treatment of Lateral Epicondylitis","status":"COMPLETED","sponsor":"Cairo University","startDate":"2025-09-15","conditions":"Lateral Epicondylitis (Tennis Elbow)","enrollment":45},{"nctId":"NCT07244991","phase":"NA","title":"Effect of MI Paste Plus™ on Streptococcus Mutans and White Spot Lesions in Fixed Orthodontics","status":"RECRUITING","sponsor":"Cardenal Herrera University","startDate":"2026-01-04","conditions":"Dental Caries, Streptococcus Mutans, Tooth Demineralization","enrollment":200},{"nctId":"NCT05997316","phase":"NA","title":"Time Restricted Eating for Metabolic and Psychological Optimization","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2023-08-07","conditions":"Mild Cognitive Impairment, Obesity","enrollment":33},{"nctId":"NCT07045038","phase":"NA","title":"Blood Flow Restricted Resistance Exercises Versus Low Level Laser on Cardiac Functions in Patients With Chronic Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2025-01-20","conditions":"Heart Failure NYHA Class II","enrollment":60},{"nctId":"NCT06628310","phase":"PHASE2","title":"A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-12-13","conditions":"Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma","enrollment":180},{"nctId":"NCT05165810","phase":"NA","title":"Evaluation of Multiple Interventions to Improve HIV Treatment Outcomes Among People Who Inject Drugs in India","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-03-09","conditions":"HIV Infections","enrollment":800},{"nctId":"NCT03952585","phase":"PHASE2, PHASE3","title":"De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-10-09","conditions":"Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8","enrollment":384},{"nctId":"NCT07497659","phase":"NA","title":"Ischemic Preconditioning in Resistance Exercise in Older Women","status":"COMPLETED","sponsor":"Universidade Federal do Triangulo Mineiro","startDate":"2025-05-28","conditions":"Blood Pressure, Hemodynamic Response, Rating of Perceived Exertion","enrollment":30},{"nctId":"NCT03569891","phase":"PHASE3","title":"HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients","status":"COMPLETED","sponsor":"CSL Behring","startDate":"2018-06-27","conditions":"Hemophilia B","enrollment":67},{"nctId":"NCT05896163","phase":"PHASE1, PHASE2","title":"A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Given Together In People With Relapsed Or Refractory Diffuse Large B Cell Lymphoma.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2023-08-30","conditions":"Diffuse Large B-Cell Lymphoma","enrollment":30},{"nctId":"NCT01900132","phase":"NA","title":"Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers","status":"RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2013-06-20","conditions":"Neuromuscular Disease, Motor Neuron Disease, Inherited Neuromuscular Conditions","enrollment":275},{"nctId":"NCT04036331","phase":"NA","title":"Dyad Plus Effectiveness/Feasibility","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2021-07-30","conditions":"Weight Loss, Pediatric Obesity, Overweight Adolescents","enrollment":90},{"nctId":"NCT04235777","phase":"PHASE1","title":"Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-07-13","conditions":"Urothelial Cancer, Bladder Cancer, Genitourinary Cancer","enrollment":100},{"nctId":"NCT03286530","phase":"PHASE2","title":"Ruxolitinib + Allogeneic Stem Cell Transplantation in AML","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2017-11-03","conditions":"Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Allogeneic Stem Cell Transplantation","enrollment":64},{"nctId":"NCT07497594","phase":"NA","title":"ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention","status":"RECRUITING","sponsor":"Oswaldo Cruz Foundation","startDate":"2026-02-03","conditions":"Contact With or Exposure to Human Immunodeficiency Virus","enrollment":1500},{"nctId":"NCT06234995","phase":"PHASE4","title":"Cortical Electrophysiology of Response Inhibition in Parkinson's Disease","status":"RECRUITING","sponsor":"Emory University","startDate":"2021-08-09","conditions":"Parkinson Disease","enrollment":80},{"nctId":"NCT07228065","phase":"NA","title":"Fixed-Dose Combinations Pragmatic Randomized Implementation Trial for Blood Pressure Control","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-05-01","conditions":"Hypertension, Primary Care","enrollment":720},{"nctId":"NCT07000539","phase":"NA","title":"Indocyanine Green Fluorescence Angiography (ICG-FA) in Revisional Bariatric Surgery","status":"RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-05-06","conditions":"Obesity, Bariatric Surgery","enrollment":108},{"nctId":"NCT06749158","phase":"NA","title":"Radiographic and Histological Assessment of GBR Using DBB Compared to Spontaneous Bone Regeneration of Maxillary Defects , Resulted From Enucleation of Intra-bony Cystic Lesions","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-12-30","conditions":"Maxillary Cyst","enrollment":44},{"nctId":"NCT07493811","phase":"NA","title":"High-Flow Nasal Oxygen During Endoscopic Retrograde Cholangiopancreatography In Geriatric Patients","status":"COMPLETED","sponsor":"Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization","startDate":"2025-04-15","conditions":"Hypoxemia, Hemodynamic Instability","enrollment":100},{"nctId":"NCT04756726","phase":"PHASE1","title":"Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"C4 Therapeutics, Inc.","startDate":"2021-04-27","conditions":"Multiple Myeloma, Lymphoma, Non-Hodgkin's","enrollment":224},{"nctId":"NCT04303117","phase":"PHASE1, PHASE2","title":"PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-07-13","conditions":"Kaposi Sarcoma","enrollment":80},{"nctId":"NCT07492914","phase":"PHASE2","title":"Neoadjuvant Sacituzumab Govitecan Plus Tagitanlimab for Resectable Head and Neck Squamous Cell Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2026-03-20","conditions":"Resected Head and Neck Cancer","enrollment":30},{"nctId":"NCT07297862","phase":"","title":"Virtual Reality Sickness Questionnaire: Psychometrics in Stroke Patients","status":"ENROLLING_BY_INVITATION","sponsor":"Abant Izzet Baysal University","startDate":"2025-07-16","conditions":"Motion Sickness","enrollment":50},{"nctId":"NCT06365853","phase":"PHASE2","title":"A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression","status":"RECRUITING","sponsor":"AbbVie","startDate":"2024-07-29","conditions":"Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive","enrollment":100},{"nctId":"NCT06441604","phase":"PHASE2","title":"Extended-release Buprenorphine as a Novel Low-dose Induction Strategy","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-10-27","conditions":"Opioid Use Disorder","enrollment":30},{"nctId":"NCT06087835","phase":"PHASE3","title":"Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2023-11-07","conditions":"Chronic Kidney Disease With High Proteinuria","enrollment":1835},{"nctId":"NCT06164730","phase":"PHASE1","title":"A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease","status":"RECRUITING","sponsor":"Verve Therapeutics, Inc.","startDate":"2024-04-30","conditions":"Heterozygous Familial Hypercholesterolemia, Premature Coronary Heart Disease","enrollment":85},{"nctId":"NCT06843824","phase":"NA","title":"A Graphene Far-infrared Intervention Study of Cognitive Status in Older Adults","status":"COMPLETED","sponsor":"Institute of Psychology, Chinese Academy of Sciences","startDate":"2025-03-10","conditions":"Mild Cognitive Impairment (MCI), Subjective Cognitive Decrease (SCD), Alzheimer's Disease(AD)","enrollment":126},{"nctId":"NCT06925724","phase":"PHASE2","title":"A Study of Ivonescimab in People With Endometrial and Cervical Cancers","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2025-04-04","conditions":"Endometrial Cancer, Cervical Cancer","enrollment":50},{"nctId":"NCT07369531","phase":"NA","title":"The Impact of Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis on Stoma-free Survival in Low Rectal Anal-preserving Surgery","status":"RECRUITING","sponsor":"The First Hospital of Jilin University","startDate":"2026-03-18","conditions":"Rectal Cancer, Surgical Anastomosis, Survival , Tumor","enrollment":520},{"nctId":"NCT07452679","phase":"NA","title":"Effectiveness of Osteopathy as an Adjunct to Optometric Vision Therapy in Vergence Disorders","status":"NOT_YET_RECRUITING","sponsor":"Jordi Zaragoza","startDate":"2026-04","conditions":"Vergence Disorders, Binocular Vision Dysfunction, Convergence Insufficiency","enrollment":100},{"nctId":"NCT07493902","phase":"NA","title":"Acupuncture for Post-Stroke Dysphagia: A Clinical Study","status":"RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2026-04","conditions":"Post-stroke Dysphagia, Acupuncture","enrollment":3232},{"nctId":"NCT07141511","phase":"PHASE1","title":"A Study to Investigate the Relative Bioavailability and Food Effect of a Fixed-Dose Combination Tablet Containing Zanubrutinib and Sonrotoclax (BG-71332) in Healthy Adults","status":"COMPLETED","sponsor":"BeOne Medicines","startDate":"2025-09-24","conditions":"Healthy Volunteers","enrollment":24},{"nctId":"NCT07094542","phase":"PHASE2","title":"Jaw Muscle Pain Post Wisdom Molar Surgery","status":"NOT_YET_RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2026-05","conditions":"Post Operative Pain, Impacted Third Molar Tooth, Muscle Pain","enrollment":80},{"nctId":"NCT07492888","phase":"PHASE2","title":"Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS)","status":"NOT_YET_RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2026-04-15","conditions":"Acute Respiratory Distress Syndrome, Severe Community-Acquired Pneum, Sepsis","enrollment":20},{"nctId":"NCT07281924","phase":"PHASE1, PHASE2","title":"Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2026-04","conditions":"Metastatic Melanoma, Liver Metastases","enrollment":15},{"nctId":"NCT07489625","phase":"EARLY_PHASE1","title":"Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain","status":"NOT_YET_RECRUITING","sponsor":"Qinghai Red Cross Hospital","startDate":"2026-03-07","conditions":"Refractory Cancer Pain, Cancer Pain","enrollment":30},{"nctId":"NCT05303532","phase":"PHASE3","title":"Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab","status":"ENROLLING_BY_INVITATION","sponsor":"AstraZeneca","startDate":"2022-04-19","conditions":"Cancer","enrollment":214},{"nctId":"NCT07348536","phase":"NA","title":"Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal","status":"NOT_YET_RECRUITING","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2026-04","conditions":"End Stage Renal Disease (ESRD), Chronic Kidney Disease on Hemodialysis, Renal Dialysis","enrollment":15},{"nctId":"NCT07489911","phase":"","title":"Fixed Triple Inhaled Combination in Asthmatic Patients in a Real-life Setting (STRENGTH)","status":"RECRUITING","sponsor":"Chiesi Slovenija, d.o.o.","startDate":"2024-11-04","conditions":"Asthma, Asthma Patients, Asthma Bronchiale","enrollment":200},{"nctId":"NCT02881320","phase":"PHASE2, PHASE3","title":"Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2016-09-21","conditions":"HIV-1 Infection","enrollment":177},{"nctId":"NCT05929664","phase":"PHASE2","title":"Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2023-07-05","conditions":"Locally Advanced Basal Cell Carcinoma, Basal Cell Carcinoma","enrollment":70},{"nctId":"NCT03899155","phase":"PHASE2","title":"Pan Tumor Rollover Study","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2019-08-09","conditions":"Cancer","enrollment":1500},{"nctId":"NCT07031518","phase":"NA","title":"Pilot Study to Identify and Validate Digital Biomarkers in Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Liege","startDate":"2025-05-14","conditions":"Osteoarthritis of the Knee","enrollment":43},{"nctId":"NCT07067138","phase":"NA","title":"A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-02-23","conditions":"Breast Cancer, Breast Carcinoma, Cancer of the Breast","enrollment":175},{"nctId":"NCT04712552","phase":"","title":"In Vivo Measurement of the Accuracy of the \"Neurolocate\" Module of the Neurosurgical Robot \"Neuromate\" in Its Application to Deep Brain Stimulation","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2021-01-26","conditions":"Parkinson Disease, Dystonia, Tremor","enrollment":18},{"nctId":"NCT06712563","phase":"","title":"Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-04-17","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":2000},{"nctId":"NCT06985485","phase":"PHASE2","title":"Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2025-05-17","conditions":"Acute Lymphoblastic Leukemia, Immunotherapy, Blinatumomab","enrollment":26},{"nctId":"NCT07357493","phase":"NA","title":"metaCARpal Bone Osteosynthesis Trail","status":"RECRUITING","sponsor":"Karolinska Institutet","startDate":"2026-03-23","conditions":"Metacarpal Shaft Fractures","enrollment":552},{"nctId":"NCT06820463","phase":"PHASE2","title":"A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-04-24","conditions":"Metastatic Colorectal Cancer","enrollment":390},{"nctId":"NCT07101926","phase":"","title":"Monitoring of Anti-TFPI in Hemophilia","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2025-10-23","conditions":"Hemophilia, Rebalancing Agents, Prophylaxis","enrollment":11},{"nctId":"NCT07325240","phase":"PHASE4","title":"24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-11-21","conditions":"Open Angle Glaucoma, Ocular Hypertension","enrollment":30},{"nctId":"NCT05917522","phase":"PHASE2","title":"Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-12-07","conditions":"Kidney Transplant","enrollment":800},{"nctId":"NCT05469997","phase":"NA","title":"Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2023-03-01","conditions":"Parkinson Disease","enrollment":52},{"nctId":"NCT07384442","phase":"NA","title":"Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's Disease Patients","status":"RECRUITING","sponsor":"YangPan","startDate":"2026-03-19","conditions":"Parkinson's Disease, Movement Disorders","enrollment":50},{"nctId":"NCT06017791","phase":"NA","title":"Management of Excess Gingival Display Using Tunnel Technique With 3D Designed PEEK Shell: A Case Series","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-11-08","conditions":"Excessive Gingival Display","enrollment":10},{"nctId":"NCT06096051","phase":"","title":"Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2023-06-13","conditions":"Intracranial Hemorrhage","enrollment":76},{"nctId":"NCT07439250","phase":"PHASE1","title":"A Study of Olomorasib (LY3537982) in Healthy Participants","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2026-03-02","conditions":"Healthy","enrollment":15},{"nctId":"NCT07475351","phase":"NA","title":"Comparison of Bone-patellar Tendon-bone and Patellar Tendon-bone Grafts in ACL Reconstruction","status":"RECRUITING","sponsor":"Universidad de Granada","startDate":"2026-01-01","conditions":"Anterior Cruciate Ligament (ACL) Reconstruction, Anterior Cruciate Ligament Injury","enrollment":110},{"nctId":"NCT07488104","phase":"NA","title":"Plantar Pressure and Acceptance of the LEEF-shoe in Individuals With Diabetes-related Neuropathy","status":"RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2026-04","conditions":"Diabetic Neuropathy","enrollment":30},{"nctId":"NCT06769698","phase":"PHASE2","title":"A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2026-03-31","conditions":"Head and Neck Squamous Cell Carcinoma (HNSCC)","enrollment":120},{"nctId":"NCT07489027","phase":"NA","title":"Comparison of Prosthetic Complications and Framework Misfit Among Different Cobalt-Chromium Framework Fabrication Techniques","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2024-01-18","conditions":"Prosthesis (Internal) Complications","enrollment":27},{"nctId":"NCT05318274","phase":"NA","title":"Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2021-04-26","conditions":"Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer","enrollment":72},{"nctId":"NCT06827236","phase":"PHASE1, PHASE2","title":"A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer","status":"RECRUITING","sponsor":"BioNTech SE","startDate":"2025-04-23","conditions":"Locally Advanced Breast Cancer, Unresectable Breast Carcinoma, Metastatic Breast Cancer","enrollment":380},{"nctId":"NCT06378268","phase":"NA","title":"PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-04-24","conditions":"Progestins Primed Ovarian Stimulation","enrollment":626},{"nctId":"NCT07449390","phase":"PHASE1","title":"Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole","status":"NOT_YET_RECRUITING","sponsor":"Acesion Pharma","startDate":"2026-04-22","conditions":"Healthy Participants","enrollment":28},{"nctId":"NCT07320963","phase":"PHASE1, PHASE2","title":"Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2026-03-31","conditions":"Nasopharyngeal Carcinoma","enrollment":52},{"nctId":"NCT06637501","phase":"PHASE2","title":"A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"BeOne Medicines","startDate":"2024-11-14","conditions":"Chronic Lymphocytic Leukemia","enrollment":94},{"nctId":"NCT05217498","phase":"PHASE1, PHASE2","title":"Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury","status":"NOT_YET_RECRUITING","sponsor":"Randy Trumbower, PT, PhD","startDate":"2027-09-01","conditions":"Spinal Cord Injuries, Myelopathy","enrollment":40},{"nctId":"NCT06379789","phase":"PHASE1, PHASE2","title":"A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2024-09-11","conditions":"Hemophilia B","enrollment":130},{"nctId":"NCT06293703","phase":"NA","title":"Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)","status":"RECRUITING","sponsor":"Salvador Navarrete","startDate":"2024-01-12","conditions":"Morbid Obesity","enrollment":262},{"nctId":"NCT04579367","phase":"","title":"Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company","startDate":"2021-01-15","conditions":"Hypercholesterolemia, Mixed Dyslipidemia","enrollment":5000},{"nctId":"NCT07054905","phase":"","title":"Prediction of Hyperkalemia in Dialysis Patients Through Waveform Analysis Using Wearable ECG","status":"COMPLETED","sponsor":"Kyungho Park","startDate":"2025-06-23","conditions":"Hyperkalemia, Chronic Kidney Disease","enrollment":32},{"nctId":"NCT07481058","phase":"PHASE2","title":"KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer","status":"RECRUITING","sponsor":"Beijing Konruns Pharmaceutical Co., Ltd.","startDate":"2025-12-12","conditions":"Esophageal Squamous Cell Carcinoma (ESCC)","enrollment":60},{"nctId":"NCT05563103","phase":"NA","title":"Combination Therapy to Improve SCI Recovery.","status":"RECRUITING","sponsor":"Spaulding Rehabilitation Hospital","startDate":"2023-01-17","conditions":"Spinal Cord Injuries","enrollment":60}],"_emaApprovals":[],"_faersSignals":[{"count":149,"reaction":"BLOOD PRESSURE INCREASED"},{"count":101,"reaction":"MALAISE"},{"count":92,"reaction":"CEREBROVASCULAR ACCIDENT"},{"count":90,"reaction":"HYPERTENSION"},{"count":88,"reaction":"DIABETES MELLITUS"},{"count":66,"reaction":"DEATH"},{"count":61,"reaction":"DRUG INEFFECTIVE"},{"count":52,"reaction":"BLOOD PRESSURE DECREASED"},{"count":50,"reaction":"FALL"},{"count":50,"reaction":"PAIN"}],"_approvalHistory":[],"publicationCount":16078,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Factor IX"],"phase":"marketed","status":"active","brandName":"FIX","genericName":"FIX","companyName":"Bioverativ Therapeutics Inc.","companyId":"bioverativ-therapeutics-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"FIX is a recombinant coagulation Factor IX that replaces deficient or dysfunctional Factor IX to restore the intrinsic coagulation pathway in patients with hemophilia B. Used for Hemophilia B (Factor IX deficiency) — prevention and treatment of bleeding episodes, Hemophilia B — perioperative management.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}